Save your place

Sign in to WhoBought

Please try again later.

Fennec Pharmaceuticals Inc. (FENC) institutional ownership

Latest close $9.90 Jul 20, 2026
Market cap$217M 52-week range SectorHealthcare
Funds holding · Q1 2026
90
reported FENC position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
52 buyers · 38 sellers

Fennec Pharmaceuticals Inc. (FENC) price and institutional activity

Dates

Q1 2026

$0 bought by 52 investors
Aigh Capital Management LLCRosalind Advisors, Inc. +50 more
$0 sold by 38 investors
Apis Capital Advisors, LLCMarshall Wace, LLP +36 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Fennec Pharmaceuticals Inc. (FENC) institutional activity · 90

Investor Type Est. change Change Δ Own Date
Aigh Capital Management LLC · Added
Change +400K Date Q1 2026
Aigh Capital Management LLC Added· Q1 2026 +400K Q1 2026
Rosalind Advisors, Inc. · Added
Change +295K Date Q1 2026
Rosalind Advisors, Inc. Added· Q1 2026 +295K Q1 2026
Apis Capital Advisors, LLC · Exited
Change −204K Δ Own −100.0% Date Q1 2026
Apis Capital Advisors, LLC Exited· Q1 2026 −204K −100.0% Q1 2026
BlackRock · Added
Change +134K Date Q1 2026
BlackRock Added· Q1 2026 +134K Q1 2026
Potomac Capital Management, Inc. · Added
Change +129K Date Q1 2026
Potomac Capital Management, Inc. Added· Q1 2026 +129K Q1 2026
Marshall Wace, LLP · Exited
Change −128K Δ Own −100.0% Date Q1 2026
Marshall Wace, LLP Exited· Q1 2026 −128K −100.0% Q1 2026
Cornerstone Capital, Inc. · New
Change +105K Date Q1 2026
Cornerstone Capital, Inc. New· Q1 2026 +105K Q1 2026
Solas Capital Management, LLC · Reduced
Change −79K Date Q1 2026
Solas Capital Management, LLC Reduced· Q1 2026 −79K Q1 2026
Geode · Added
Change +75K Date Q1 2026
Geode Added· Q1 2026 +75K Q1 2026
Thompson Siegel & Walmsley LLC · New
Change +57K Date Q1 2026
Thompson Siegel & Walmsley LLC New· Q1 2026 +57K Q1 2026
Gendell Jeffrey L · Reduced
Change −57K Date Q1 2026
Gendell Jeffrey L Reduced· Q1 2026 −57K Q1 2026
Eleva Capital Sas · New
Change +53K Date Q1 2026
Eleva Capital Sas New· Q1 2026 +53K Q1 2026
Stonepine Capital Management, LLC · Exited
Change −50K Δ Own −100.0% Date Q1 2026
Stonepine Capital Management, LLC Exited· Q1 2026 −50K −100.0% Q1 2026
Citadel Advisors LLC Reduced· Q1 2026 −46K −23.1% Q1 2026
Hillsdale Investment Management Inc. · Exited
Change −44K Δ Own −100.0% Date Q1 2026
Hillsdale Investment Management Inc. Exited· Q1 2026 −44K −100.0% Q1 2026
Data through Q1 2026 · filed May 21, 2026
15 of 90

Famous investor activity in Fennec Pharmaceuticals Inc. (FENC)

Fennec Pharmaceuticals Inc. (FENC) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Raykov Rosty · Other Sell −$100K
Price $10.41 Qty −10K Owned 139K ΔOwn −6.5% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Raykov Rosty Other Sell $10.41 −10K −$100K 139K −6.5% Jul 1, 2026 Jul 2, 2026
Raykov Rosty · Other 2 operations $0
Price $2.45 Qty 0 Owned 1.5M Trade date Jul 1, 2026 Filed date Jul 2, 2026
Raykov Rosty Other 2 operations $2.45 0 $0 1.5M Jul 1, 2026 Jul 2, 2026
Raykov Rosty · Other Grant (A) 3K
Owned 133K ΔOwn +2.1% Trade date Jul 1, 2026 Filed date Jul 2, 2026
Raykov Rosty Other Grant (A) 3K 133K +2.1% Jul 1, 2026 Jul 2, 2026
Evans Terry L. · Officer Grant (A) 168
Owned 21K ΔOwn +0.8% Trade date Jun 30, 2026 Filed date Jul 1, 2026
Evans Terry L. Officer Grant (A) 168 21K +0.8% Jun 30, 2026 Jul 1, 2026
Sayad Pierre Sargis · Officer Grant (A) 168
Owned 21K ΔOwn +0.8% Trade date Jun 30, 2026 Filed date Jul 1, 2026
Sayad Pierre Sargis Officer Grant (A) 168 21K +0.8% Jun 30, 2026 Jul 1, 2026
Hackman Jeffrey S. · Director Grant (A) 1K
Owned 64K ΔOwn +1.8% Trade date Jun 30, 2026 Filed date Jul 1, 2026
Hackman Jeffrey S. Director Grant (A) 1K 64K +1.8% Jun 30, 2026 Jul 1, 2026
Andrade Robert · Officer Grant (A) 2K
Owned 291K ΔOwn +0.6% Trade date Jun 30, 2026 Filed date Jul 1, 2026
Andrade Robert Officer Grant (A) 2K 291K +0.6% Jun 30, 2026 Jul 1, 2026
Cioffi Christiana Marie · Officer Grant (A) 156
Owned 24K ΔOwn +0.6% Trade date Jun 30, 2026 Filed date Jul 1, 2026
Cioffi Christiana Marie Officer Grant (A) 156 24K +0.6% Jun 30, 2026 Jul 1, 2026
Brughera Marco Maria · Director Grant (A) $174K
Price $8.70 Qty 20K Owned 236K Trade date Jun 10, 2026 Filed date Jun 10, 2026
Brughera Marco Maria Director Grant (A) $8.70 20K $174K 236K Jun 10, 2026 Jun 10, 2026
Cook Jodi A. · Director Grant (A) $174K
Price $8.70 Qty 20K Owned 160K Trade date Jun 10, 2026 Filed date Jun 10, 2026
Cook Jodi A. Director Grant (A) $8.70 20K $174K 160K Jun 10, 2026 Jun 10, 2026
Islam Khalid · Director Grant (A) $217K
Price $8.70 Qty 25K Owned 250K Trade date Jun 10, 2026 Filed date Jun 10, 2026
Islam Khalid Director Grant (A) $8.70 25K $217K 250K Jun 10, 2026 Jun 10, 2026
Rallis Chris A. · Director Grant (A) $174K
Price $8.70 Qty 20K Owned 200K Trade date Jun 10, 2026 Filed date Jun 10, 2026
Rallis Chris A. Director Grant (A) $8.70 20K $174K 200K Jun 10, 2026 Jun 10, 2026
Raykov Rosty · Director Sell −$94K
Price $9.62 Qty −10K Owned 130K Trade date Jun 1, 2026 Filed date Jun 2, 2026
Raykov Rosty Director Sell $9.62 −10K −$94K 130K Jun 1, 2026 Jun 2, 2026
Raykov Rosty · Director 2 operations $0
Price $2.45 Qty 0 Owned 1.6M Trade date Jun 1, 2026 Filed date Jun 2, 2026
Raykov Rosty Director 2 operations $2.45 0 $0 1.6M Jun 1, 2026 Jun 2, 2026
Raykov Rosty · Director Grant (A) 3K
Owned 124K Trade date May 31, 2026 Filed date Jun 2, 2026
Raykov Rosty Director Grant (A) 3K 124K May 31, 2026 Jun 2, 2026
15 of 93
15 of 93 Sign in to continue to older insider transactions.

Fennec Pharmaceuticals Inc. (FENC) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Sonic Gp LLC 2.4M
% of shares outstanding 9.2% Filing date Feb 14, 2023
Sonic Gp LLC 2.4M 9.2% Feb 14, 2023
Rosalind Advisors, Inc. 3.0M
% of shares outstanding 8.8% Filing date May 14, 2026
Rosalind Advisors, Inc. 3.0M 8.8% May 14, 2026
Sonic Fund Ii, L.P. 2.6M
% of shares outstanding 7.6% Filing date Feb 17, 2026
Sonic Fund Ii, L.P. 2.6M 7.6% Feb 17, 2026
Solas Capital Management, LLC 2.5M
% of shares outstanding 7.2% Filing date May 15, 2026
Solas Capital Management, LLC 2.5M 7.2% May 15, 2026
Orin Hirschman 2.0M
% of shares outstanding 5.7% Filing date Apr 28, 2026
Orin Hirschman 2.0M 5.7% Apr 28, 2026
Dg Capital Management, LLC 1.1M
% of shares outstanding 4.1% Filing date Feb 14, 2025
Dg Capital Management, LLC 1.1M 4.1% Feb 14, 2025
6 of 6

Fennec Pharmaceuticals Inc. (FENC) ownership FAQ

Who owns FENC?

90 reporting institutions disclosed FENC position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.